Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 90
Filter
1.
Thorac Cardiovasc Surg ; 55(1): 48-52, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17285474

ABSTRACT

BACKGROUND: Following successful lung transplantation, most of the lung perfusion, as well as ventilation, is shifted towards the transplanted lung. We investigated the changes in perfusion during exercise in lung transplant recipients. PATIENTS AND METHODS: Twelve patients were included in the study. Six patients had emphysema and 6 patients had idiopathic pulmonary fibrosis (IPF). Patients underwent two upright lung perfusion scans: the first at rest and the second during a maximal cardiopulmonary exercise test. Lung perfusion was assessed in each lung and regionally. RESULTS: At rest, patients with emphysema had 83.3 +/- 8 % of total perfusion to the transplanted side and 16.7 +/- 8 % to the native lung, while in the IPF patients, it was 68.7 +/- 12 and 32.7 +/- 10 %, respectively ( P = 0.028). At peak exercise, perfusion shifted from the transplanted lung to the native lung ( P = 0.0095) both in emphysema and IPF patients. CONCLUSIONS: Following successful lung transplantation, most of the perfusion is directed towards the transplanted lung. During exercise, there was a small but significant shift towards the native lung. These findings highlighted the important role of the native lung during maximal exercise.


Subject(s)
Lung Transplantation/physiology , Pulmonary Circulation/physiology , Pulmonary Emphysema/physiopathology , Pulmonary Fibrosis/physiopathology , Ventilation-Perfusion Ratio/physiology , Adult , Aged , Female , Follow-Up Studies , Humans , Lung Transplantation/diagnostic imaging , Male , Middle Aged , Physical Exertion/physiology , Postoperative Period , Pulmonary Diffusing Capacity/physiology , Pulmonary Emphysema/diagnostic imaging , Pulmonary Emphysema/surgery , Pulmonary Fibrosis/diagnostic imaging , Pulmonary Fibrosis/surgery , Radionuclide Imaging , Radiopharmaceuticals , Retrospective Studies , Technetium Tc 99m Aggregated Albumin
2.
Eur J Gynaecol Oncol ; 24(5): 433-4, 2003.
Article in English | MEDLINE | ID: mdl-14584664

ABSTRACT

A case of a 70-year-old patient with advanced local vulvar cancer is presented. Treatment with neo-adjuvant chemo-radiotherapy for two courses was administered and two weeks after completion of treatment the patient underwent wide local excision with bilateral inguino-femoral lymph node dissection through three separate incisions. Two methods for the evaluation of sentinel nodes--lymphoscintigraphy and intraoperative gamma hand-held probe and blue dye injection, did not detect any sentinel node on either side. Groin-node dissection revealed 23 negative nodes. It is our hypothesis that the non-visualization of sentinel nodes in this patient was due to post-irradiation damage to the lymph channels.


Subject(s)
Carcinoma, Squamous Cell/therapy , Lymph Nodes/pathology , Sentinel Lymph Node Biopsy , Vulvar Neoplasms/therapy , Aged , Carcinoma, Squamous Cell/pathology , Female , Humans , Lymph Node Excision , Lymph Nodes/radiation effects , Neoadjuvant Therapy , Vulvar Neoplasms/pathology
3.
Mov Disord ; 16(6): 1041-7, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11748735

ABSTRACT

Gastrointestinal symptoms such as nausea, abdominal pain, and bloating are frequent complaints of patients with Parkinson's disease (PD). It has been postulated that impaired gastrointestinal function may contribute to the development of motor fluctuations such as delay on and no on in patients with PD. Gastrointestinal impaired function and symptoms may be associated with the disease itself or secondary to levodopa treatment. Thus, we assessed gastric emptying (GE) and gastric motility in PD patients to examine the association between clinical status and gastric function. GE and antral contraction (frequency and amplitude) were evaluated by scintigraphy in 29 patients with mild PD (Hoehn and Yahr [H&Y] stage 1.0-2.0); 22 patients with moderate PD (H&Y stage 2.5-3.0); and 22 healthy volunteers, following the ingestion of a labeled standard meal. Gastric emptying (mean +/- SD of T(1/2)) and antral contraction were not significantly different between patients with mild PD (63.4 +/- 28.8 minutes) and moderate PD (54.7 +/- 25.5 minutes). In the control group, GE was 43.4 +/- 10.8 minutes (range 29.0 - 61.0 minutes). The prevalence of delayed emptying (>61 minutes) was not significantly different in patients with mild disease (48.3%) as compared with patients with moderate disease (36.4%). Antral contraction, both frequency and amplitude, were not significantly different between patients with mild and moderate PD throughout the entire 100 minutes of the study. Untreated patients (n = 28) had mean GE T(1/2) of 59 +/- 30.6 minutes. Patients with smooth response to levodopa showed slower GE (n = 10; 73.6 +/- 25.3 minutes), while treated patients with motor response fluctuations when tested at the on state (n = 13), had much faster GE (49.3 +/- 16.2 minutes). This shortened GE in the on state was similar to the GE of normal volunteers. We conclude that gastric emptying time in patients with PD was delayed compared with control volunteers. It was even slower in patients treated with levodopa. This effect of levodopa treatment was reversed to pseudonormalization (normal GE) at the advanced stages of the disease, when patients developed motor response fluctuation. Other clinical features of PD were not associated with delayed gastric emptying.


Subject(s)
Antiparkinson Agents/adverse effects , Gastric Emptying/drug effects , Levodopa/adverse effects , Parkinson Disease/physiopathology , Aged , Antiparkinson Agents/pharmacokinetics , Case-Control Studies , Disease Progression , Female , Gastrointestinal Motility/drug effects , Humans , Levodopa/pharmacokinetics , Male , Middle Aged , Parkinson Disease/diagnostic imaging , Parkinson Disease/drug therapy , Radiopharmaceuticals , Severity of Illness Index , Technetium Tc 99m Aggregated Albumin , Tomography, Emission-Computed/methods
4.
Br J Cancer ; 85(4): 504-8, 2001 Aug 17.
Article in English | MEDLINE | ID: mdl-11506487

ABSTRACT

This study was designed to determine response rate, survival and toxicity associated with combination chemotherapy delivered intra-arterially to liver in patients with hepatic metastases of colorectal origin refractory to standard systemic treatment. A total of 28 patients who failed prior systemic treatment with fluoropyrimidines received a median of 5 cycles of intra-arterial treatment consisting of 5-fluorouracil 700 mg/m(2)/d, leucovorin 120 mg/m(2)/d, and cisplatin 20 mg/m(2)/d for 5 consecutive days. Cycles were repeated at intervals of 5-6 weeks. A major response was achieved in 48% of patients: complete response in 8% and partial response in 40%. The median duration of response was 11.5 months. Median survival was 12 months at a median follow up of 12 months. On multivariate analysis, the only variables with a significant impact on survival were response to treatment and performance status. Toxicity was moderate: grades III-IV neutropenia occurred in 29% of patients. Most of the patients complained of fatigue lasting for a few days following each cycle. There were no cases of hepatobiliary toxicity. These findings indicate that regional intra-arterial treatment should be considered in selected patients with predominantly liver disease following failure of standard treatment.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Colorectal Neoplasms/pathology , Liver Neoplasms/drug therapy , Liver Neoplasms/secondary , Adult , Aged , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Cisplatin/administration & dosage , Drug Resistance, Neoplasm , Fatigue/chemically induced , Female , Fluorouracil/administration & dosage , Humans , Infusions, Intra-Arterial , Leucovorin/administration & dosage , Male , Middle Aged , Neutropenia/chemically induced , Survival Analysis , Treatment Outcome
7.
Clin Nucl Med ; 25(12): 1013-6, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11129136

ABSTRACT

Two children with juvenile dermatomyositis and extensive, debilitating soft tissue calcifications are described. Whole-body bone scans with Tc-99m MDP were performed in both cases before and during specific treatment for the calcinosis. Baseline studies showed marked tracer localization in the soft tissues and provided an objective baseline assessment of the extent of the soft tissue calcifications. Follow-up studies showed gradual clearance of the extraskeletal uptake and were useful in monitoring the therapeutic response. These cases show that skeletal scintigraphy can function as a useful auxiliary tool to evaluate calcinosis in children with juvenile dermatomyositis.


Subject(s)
Calcinosis/diagnostic imaging , Dermatomyositis/diagnostic imaging , Radiopharmaceuticals , Technetium Tc 99m Medronate , Bone and Bones/diagnostic imaging , Calcinosis/complications , Calcinosis/drug therapy , Child, Preschool , Dermatomyositis/complications , Dermatomyositis/drug therapy , Female , Follow-Up Studies , Humans , Male , Radionuclide Imaging , Time Factors
8.
J Nucl Med ; 41(11): 1771-6, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11079482

ABSTRACT

UNLABELLED: The objective of this study was to evaluate the role of quantitative perfusion lung scintigraphy (QPLS) in predicting the development of chronic rejection in patients who underwent single-lung transplantation. METHODS: Eighteen patients (15 men, 3 women; age range, 41-60 y; mean age, 54.6+/-6.0 y) who underwent single-lung transplantation for emphysema (n = 14) or pulmonary fibrosis (n = 4) were studied. Patients were evaluated using QPLS and pulmonary function tests before surgery and at 1-3 mo and 1-3 y after transplantation. Relative perfusion of the transplanted lung was calculated from standard perfusion lung scintigrams. Values for forced expiratory volume in the first second (FEV1) were obtained from lung function tests at the same time points. The maximal and minimal relative perfusion and FEV1 values in the early (1-3 mo) and late (1-3 y) follow-up periods were identified for each patient. Receiver operating curve (ROC) analysis was performed on all parameters. RESULTS: In total, 82 lung scans were performed (mean, 4.8+/-1.55 per patient) and 484 FEV1 test determinations were obtained (mean, 30.0+/-15.6 per patient) during a follow-up period ranging from 8 to 84 mo (mean, 39.6+/-19.3 mo). In 7 of the 18 patients, chronic rejection developed, whereas 11 patients had a favorable outcome. No significant difference was found in the number of complications (acute rejection and infection episodes) between patients with a favorable outcome and patients with chronic rejection, up to 1 y after transplantation. At 1-3 mo, minimal relative perfusion values were 67.1%+/-12.2% in the favorable outcome group and 50.8%+/-9.6% in the chronic rejection group (P = 0.02). Before surgery and at 1-3 y, minimal relative perfusion was not significantly different between the 2 groups. The difference in maximal relative perfusion at 1-3 y was marginally significant, with 76.5%+/-8.9% in the favorable group and 64.3%+/-15.0% in the chronic rejection group (P = 0.051). FEV1 values were not significantly different preoperatively and 1-3 mo after surgery between the chronic rejection and the favorable outcome groups. Late in the follow-up period (1-3 y), FEV1 values in the chronic rejection and favorable outcome groups were 35.6%+/-7.9% and 56.9%+/-13.6%, respectively (P = 0.002). ROC analysis of minimal relative perfusion at 1-3 mo identified a threshold of 57% under which the sensitivity and specificity for chronic rejection were 83% and 88%, respectively. Minimal FEV1 for the same period identified a threshold of 48% under which the sensitivity and the specificity were 80% and 67%, respectively. CONCLUSION: QPLS early after transplantation in our patients predicted the development of chronic rejection in patients with single-lung transplantation for emphysema and pulmonary fibrosis, whereas surgical complications, acute rejection, infection episodes, and lung function tests did not predict the outcome. This early prediction could not be obtained from lung function tests performed at the same time.


Subject(s)
Lung Transplantation , Lung/diagnostic imaging , Pulmonary Emphysema/surgery , Pulmonary Fibrosis/surgery , Adult , Female , Follow-Up Studies , Forced Expiratory Volume , Graft Rejection/diagnostic imaging , Humans , Male , Middle Aged , Prognosis , Pulmonary Emphysema/diagnostic imaging , Pulmonary Emphysema/physiopathology , Pulmonary Fibrosis/diagnostic imaging , Pulmonary Fibrosis/physiopathology , ROC Curve , Radionuclide Imaging , Sensitivity and Specificity
9.
Exp Clin Endocrinol Diabetes ; 108(3): 237-40, 2000.
Article in English | MEDLINE | ID: mdl-10926323

ABSTRACT

The possible role of gonadal steroids and gonadotropins in regulating melatonin secretion has been suggested in clinical syndromes of the hypothalamic-pituitary-gonadal axis. We describe the results of melatonin secretion in a 37-year old male patient who presented with azoospermia. The patient was an XX male, had classic simple virilizing form of 21-hydroxylase deficiency, which led to a masculine phenotype. He was ovariectomized at the age of three years and reared as a male. Melatonin production (aMT6s) was determined at baseline and during 12 months of replacement therapy. Results were compared with those obtained in age-matched male controls. Pretreatment aMT6s values were decreased (14.3 microg/24 h vs. 29.0+/-5.5 in controls). Dexamethasone replacement was associated with an increase in aMT6s values (19.3-20.9 microg/24 h). The addition of testosterone to dexamethasone replacement resulted in normalization of aMT6s (27.6-33.1 microg/24 h) and serum 17OH progesterone, testosterone and estradiol levels. The present data indicate that androgen excess due to 21 hydroxylase deficiency is associated with decreased melatonin secretion. These results support the hypothesis that sex steroids modulate melatonin secretion.


Subject(s)
Adrenal Hyperplasia, Congenital , Gonadal Dysgenesis, 46,XY/genetics , Melatonin/analogs & derivatives , Melatonin/metabolism , 17-alpha-Hydroxyprogesterone/blood , Adult , Dehydroepiandrosterone Sulfate/blood , Dexamethasone/therapeutic use , Estradiol/blood , Female , Follicle Stimulating Hormone/blood , Gonadal Dysgenesis, 46,XY/blood , Gonadal Dysgenesis, 46,XY/physiopathology , Hormone Replacement Therapy , Humans , Hydrocortisone/blood , Luteinizing Hormone/blood , Male , Melatonin/urine , Oligospermia , Ovariectomy , Testosterone/blood , Testosterone/therapeutic use
10.
Clin Nucl Med ; 25(6): 410-3, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10836685

ABSTRACT

PURPOSE: Tc-99m MIBI has been used increasingly to evaluate benign and malignant tumors because of its tumor-seeking properties and ability to provide an imaging assessment of multiple-drug resistance. This study investigated the clinical utility of Tc-99m MIBI in the management of Ewing's sarcoma in children. METHODS: Thirteen Tc-99m MIBI studies in nine (six male, three female) patients ages 6.5 to 20 years (mean, 13.4 years) with Ewing's sarcoma were reviewed. All patients had imaging studies at diagnosis, and four had follow-up studies during or after therapy. Scintigraphy was evaluated for Tc-99m MIBI uptake within the tumor and in metastases, which other imaging modalities had shown to be present in four patients. Scintigraphic results were correlated with the clinical course in all patients and with tumor P-glycoprotein status in six patients. RESULTS: Tc-99m MIBI accumulated in 6 of 9 primary tumors and did not accumulate in one recurrent tumor. No metastases showed Tc-99m MIBI uptake. The presence or absence of Tc-99m MIBI uptake at diagnosis or after therapy carried no prognostic significance. Tc-99m MIBI was present in the two tumors that were P-glycoprotein positive and in only one of four tumors that were P-glycoprotein negative. CONCLUSION: Tc-99m MIBI imaging does not appear to be useful in Ewing's sarcoma.


Subject(s)
Bone Neoplasms/diagnostic imaging , Radiopharmaceuticals , Sarcoma, Ewing/diagnostic imaging , Technetium Tc 99m Sestamibi , ATP Binding Cassette Transporter, Subfamily B, Member 1/analysis , Adolescent , Adult , Bone Neoplasms/pathology , Bone Neoplasms/therapy , Child , Drug Resistance, Multiple , Drug Resistance, Neoplasm , Female , Femoral Neoplasms/diagnostic imaging , Femoral Neoplasms/therapy , Follow-Up Studies , Humans , Lung Neoplasms/diagnostic imaging , Lung Neoplasms/secondary , Male , Neoplasm Recurrence, Local/diagnostic imaging , Pelvic Bones/diagnostic imaging , Prognosis , Radionuclide Imaging , Retrospective Studies , Sarcoma, Ewing/pathology , Sarcoma, Ewing/secondary , Sarcoma, Ewing/therapy
13.
J Nucl Med ; 39(9): 1614-7, 1998 Sep.
Article in English | MEDLINE | ID: mdl-9744354

ABSTRACT

UNLABELLED: Bone loss is a major complication of primary hyperparathyroidism (PHPT), and it has significant implications in the treatment of this disease. Bone turnover was measured in patients with PHPT, using quantitative bone SPECT (QBS), to determine if the rate of bone loss could be predicted before a significant decrease in bone mass occurs. METHODS: Forty-six patients were included in the study. QBS and bone mineral density (BMD) of the lumbar spine (LS) and femoral neck (FN) were done at baseline. The percent deviation of QBS in patients with PHPT from the values in normal matched controls was calculated. BMD was measured again after a mean of 17.5 mo in 38 patients, and in 29 patients a repeat BMD study was done after a mean of 41.4 mo. The change in BMD in patients with high and normal QBS values was compared using the nonparametric Mann-Whitney test. Regression analysis tested the correlation between baseline QBS values and BMD changes over time. RESULTS: For the FN, there was a statistically significant difference in the BMD change between patients with high and normal QBS values for short-term follow-up (-2.82%+/-4.80% versus 1.45%+/-4.67%, p < 0.05) and for long-term follow-up (-3.53%+/-5.34% versus 0.92%+/-2.40, p < 0.02). There was a negative correlation in the FN, r=-0.48 between QBS values and the percentage of change in BMD. There was no significant difference between the percentage of change in BMD in the LS in patients with high and normal QBS values for either short- or long-term follow-up. CONCLUSION: The results of this study show that QBS can predict bone loss in the FN in patients with PHPT. QBS can thus indicate the need for surgery at an early stage of the disease to prevent bone loss.


Subject(s)
Bone Resorption/diagnostic imaging , Hyperparathyroidism/diagnostic imaging , Tomography, Emission-Computed, Single-Photon , Adult , Aged , Bone Density , Bone Resorption/etiology , Female , Femur Neck/diagnostic imaging , Humans , Hyperparathyroidism/complications , Longitudinal Studies , Lumbar Vertebrae/diagnostic imaging , Male , Middle Aged , Radiopharmaceuticals , Technetium Tc 99m Medronate
15.
J Pediatr Endocrinol Metab ; 10(2): 237-41, 1997.
Article in English | MEDLINE | ID: mdl-9364360

ABSTRACT

We describe a 13 year-old Ethiopian girl with vitamin D deficiency rickets. Hypercalcemia, increased serum alkaline phosphatase and PTH levels, together with low serum levels of 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D suggested the co-existence of primary hyperparathyroidism. The surgical removal of a parathyroid adenoma led to bone healing and normalization of blood chemistry. We conclude that vitamin D deficiency masked the hyperparathyroidism and hypercalcemia, while excess PTH secretion delayed the cure of rickets until successful parathyroidectomy had been carried out.


Subject(s)
Adenoma/complications , Hyperparathyroidism/complications , Parathyroid Neoplasms/complications , Rickets/etiology , Vitamin D Deficiency/complications , Adenoma/diagnosis , Adenoma/surgery , Adolescent , Alkaline Phosphatase/blood , Calcium/therapeutic use , Ergocalciferols/therapeutic use , Ethiopia , Female , Humans , Hypercalcemia/complications , Hypercalcemia/diagnosis , Hyperparathyroidism/diagnosis , Parathyroid Hormone/blood , Parathyroid Neoplasms/diagnosis , Parathyroid Neoplasms/surgery , Parathyroidectomy , Rickets/diagnosis , Vitamin D Deficiency/diagnosis
16.
J Nucl Cardiol ; 4(1 Pt 1): 25-32, 1997.
Article in English | MEDLINE | ID: mdl-9138836

ABSTRACT

BACKGROUND: Fiber dropout and myocyte necrosis precede heart failure in experimental aortic regurgitation (AR). The current study aimed to determine whether this process can be detected by noninvasive scintigraphic imaging. METHODS AND RESULTS: 111In-labeled antimyosin antibody Fab fragment (1 to 1.5 mCi) (Myoscint) was administered to each of 34 New Zealand White rabbits: 11 early (3 to 5 weeks) after surgical AR induction; 9 late (98 to 128 weeks) after AR induction; 5 normal and 3 sham-operated age-matched with early AR; and 3 normal and 3 sham-operated age-matched with late AR. Echocardiographic fractional shortening was indistinguishable among control, early AR, and late AR groups. In vivo gamma camera imaging 24 and 48 hours after isotope administration, post-mortem heart activity determination (percentage injected dose per gram), and autoradiography were performed. At 24 and 48 hours, heart-to-lung counts-per-pixel ratios from in vivo images were greater (p < 0.05) in the late AR rabbits than in each of the three other groups. No significant differences were found when early AR and older or younger control rabbits were compared. Heart activity (percentage injected dose per gram) in late AR rabbits trended toward higher values than in age-matched control rabbits (p = 0.057), but in early AR it was indistinguishable from that in the corresponding control (p = 0.413, difference not significant). The autoradiographic endocardial/epicardial activity ratio in late AR rabbits was greater than in control and early AR rabbits (1.27 +/- 0.13 vs 1.06 +/- 0.09 and vs 1.13 +/- 0.10, respectively, p < 0.02). CONCLUSIONS: Whereas isotope uptake in late AR rabbits differed from that in control and early AR rabbits, systolic function was indistinguishable. Thus 111In-labeled antimyosin antibody imaging may permit noninvasive detection of AR-induced myocardial damage before functional deterioration.


Subject(s)
Antibodies, Monoclonal , Aortic Valve Insufficiency/diagnostic imaging , Indium Radioisotopes , Myosins , Organometallic Compounds , Radiopharmaceuticals , Animals , Aortic Valve Insufficiency/metabolism , Aortic Valve Insufficiency/pathology , Autoradiography , Cardiac Output, Low/pathology , Case-Control Studies , Echocardiography, Doppler , Endocardium/diagnostic imaging , Endocardium/metabolism , Endocardium/pathology , Follow-Up Studies , Heart/diagnostic imaging , Indium Radioisotopes/pharmacokinetics , Lung/diagnostic imaging , Lung/metabolism , Lung/pathology , Muscle Fibers, Skeletal/pathology , Myocardium/metabolism , Myocardium/pathology , Myosins/pharmacokinetics , Necrosis , Pericardium/diagnostic imaging , Pericardium/metabolism , Pericardium/pathology , Rabbits , Radionuclide Imaging , Radiopharmaceuticals/pharmacokinetics , Systole
17.
J Nucl Med ; 37(8): 1371-3, 1996 Aug.
Article in English | MEDLINE | ID: mdl-8708777

ABSTRACT

A 59-yr-old man with chronic renal failure was admitted for evaluation of generalized skeletal pain and frontal bone mass, which was lytic on radiography. Bone scintigraphy demonstrated several foci of moderately increased uptake, without involvement of the skull mass. Radiographs of these lesions were compatible with brown tumors. Serum parathormone level was elevated and CT demonstrated a lower right cervical mass, consistent with parathyroid tumor. Following the removal of the mass and decrease in parathormone levels, the patient suffered from a prolonged period of hypocalcemia and his bone pain worsened. Repeat bone scintigraphy showed an increase in the number and intensity of the areas of focal uptake, consistent with hungry bone syndrome. This flare-up phenomenon is due to an increase in bone metabolism and is an uncommon finding following parathyroidectomy for primary hyperparathyroidism.


Subject(s)
Bone Diseases, Metabolic/diagnostic imaging , Bone and Bones/diagnostic imaging , Kidney Failure, Chronic/complications , Parathyroidectomy/adverse effects , Bone Diseases, Metabolic/etiology , Carcinoma/complications , Carcinoma/diagnostic imaging , Carcinoma/surgery , Humans , Hyperparathyroidism/etiology , Hyperparathyroidism/surgery , Hypocalcemia/etiology , Male , Middle Aged , Parathyroid Neoplasms/complications , Parathyroid Neoplasms/diagnostic imaging , Parathyroid Neoplasms/surgery , Radionuclide Imaging , Technetium Tc 99m Medronate
19.
J Clin Epidemiol ; 49(1): 67-71, 1996 Jan.
Article in English | MEDLINE | ID: mdl-8598513

ABSTRACT

To assess the reliability of bone scintigraphy, a random sample of 100 bone scans was reviewed twice by each of two physicians. Observer variation in the description and interpretation of bone scintigrams varied by diagnosis. Good to excellent k values were obtained for inter- and intraobserver variation in relation to metastasis or normal scans. For degenerative bone disease, as well as the specific agreement on major pathologies other than metastases, k values were found to be moderate. The agreement on the need for further radiographic studies was poor to moderate. The interpretation of bone metastases or normal scintigrams was found to be more reliable in a research setting than in the usual clinical framework, and the latter requires improvement. The interpretation of bone scintigraphy as consistent with degenerative changes is not reliable. The diagnosis should be evaluated by radiography.


Subject(s)
Bone Neoplasms/diagnostic imaging , Bone and Bones/diagnostic imaging , Data Interpretation, Statistical , Female , Humans , Male , Middle Aged , Observer Variation , Radionuclide Imaging , Reproducibility of Results , Technetium Tc 99m Medronate/analogs & derivatives
SELECTION OF CITATIONS
SEARCH DETAIL
...